ARYA SCIENCES ACQUISITION CORP.

ARYA Sciences Acquisition Corp. (Nasdaq: ARYA), sponsored by Perceptive Advisors, is a blank-check company that completed its initial public offering in 2020 and targets the life sciences and biopharmaceutical sector. The SPAC filed an 8-K with the Securities and Exchange Commission on June 29, 2020, under accession number 0001193125-20-182624, disclosing a material corporate event consistent with the company's active search for a qualifying acquisition target in the healthcare and drug development space. Perceptive Advisors, a New York-based healthcare-focused investment manager, serves as the sponsor and brings sector expertise to the SPAC's deal-sourcing process. For full filing details, transaction timelines, and analytical data on ARYA and hundreds of other SPACs, sign up for a SpacDesk account at SpacDesk.com.